|
MOBKL1B expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.615800E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.551720E-02 |
| Normal-vs-Stage2 |
1.943110E-03 |
| Normal-vs-Stage3 |
2.780000E-03 |
| Normal-vs-Stage4 |
5.636400E-03 |
| Stage1-vs-Stage2 |
1.302190E-01 |
| Stage1-vs-Stage3 |
2.370200E-01 |
| Stage1-vs-Stage4 |
3.343600E-01 |
| Stage2-vs-Stage3 |
5.625400E-01 |
| Stage2-vs-Stage4 |
6.249400E-01 |
| Stage3-vs-Stage4 |
9.588200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.804600E-03 |
| Normal-vs-AfricanAmerican |
3.794800E-01 |
| Normal-vs-Asian |
2.958600E-03 |
| Caucasian-vs-AfricanAmerican |
3.713400E-01 |
| Caucasian-vs-Asian |
2.780400E-01 |
| AfricanAmerican-vs-Asian |
1.137800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.448400E-04 |
| Normal-vs-Female |
8.962700E-03 |
| Male-vs-Female |
7.826000E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.545800E-02 |
| Normal-vs-Age(41-60Yrs) |
1.033150E-04 |
| Normal-vs-Age(61-80Yrs) |
6.236700E-03 |
| Normal-vs-Age(81-100Yrs) |
2.751800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.200010E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.687800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.853400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.880200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.764200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.034800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.654200E-01 |
| Classical-VS-Follicular |
3.203900E-03 |
| Classical-VS-Other |
1.478610E-01 |
| Classical-VS-Normal |
2.581900E-02 |
| Tall-VS-Follicular |
9.564500E-02 |
| Tall-VS-Other |
1.910370E-01 |
| Tall-VS-Normal |
1.283430E-01 |
| Follicular-VS-Other |
6.507600E-01 |
| Follicular-VS-Normal |
1.014400E-04 |
| Other-VS-Normal |
2.302500E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.015000E-04 |
| Normal-vs-N1 |
3.475200E-03 |
| N0-vs-N1 |
8.393400E-01 |
|
|
